Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Pazopanib | 100mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C21H23N7O2S. CAS No. 444731-52-6. Prepack ID 13031030-100mg. Molecular Weight 437.52. See USA prepack pricing. |  |
| Pazopanib | Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1 , VEGFR2 , VEGFR3 , PDGFRβ , c-Kit , FGFR1 , and c-Fms with IC 50 s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: GW786034. CAS No. 444731-52-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-10208. |  |
| Pazopanib-d3 Hydrochloride | Pazopanib-d3 Hydrochloride. Group: Biochemicals. Alternative Names: Votrient-d3 Hydrochloride; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide-d3 Hydrochloride. Grades: Highly Purified. Pack Sizes: 5mg. Molecular Formula: C21H21D3ClN7O2S, Molecular Weight: 477. US Biological Life Sciences. |  Worldwide |
| Pazopanib HCI | Pazopanib HCI. Uses: For analytical and research use. Group: Impurity standards. CAS No. 635702-64-6. Molecular Formula: C21H24ClN7O2S. Mole Weight: 473.98. Catalog: APB635702646. |  |
| Pazopanib HCl | Pazopanib is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM, respectively. Synonyms: TMC-114, UIC 94017. Grades: >98%. CAS No. 635702-64-6. Molecular formula: C21H23N7O2·HCl. Mole weight: 473.98. |  |
| Pazopanib Hydrochloride | Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1 , VEGFR2 , VEGFR3 , PDGFRβ , c-Kit , FGFR1 , and c-Fms with an IC 50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: GW786034 Hydrochloride. CAS No. 635702-64-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-12009. | |
| Pazopanib Impurity 1 | An impurity of Pazopanib which is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms. Grades: > 95%. CAS No. 1313372-75-6. Molecular formula: C8H7N3O2. Mole weight: 177.16. | |
| Pazopanib Impurity 1 | Pazopanib Impurity 1. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C18H20N6. Mole Weight: 320.4. Catalog: APB08863. | |
| Pazopanib Impurity 2 | An impurity of Pazopanib whic is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM, respectively. Grades: > 95%. Molecular formula: C9H9N3O2. Mole weight: 191.19. | |
| Pazopanib Impurity 2 | Pazopanib Impurity 2. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C16H17N5O4. Mole Weight: 343.34. Catalog: APB08870. | |
| Pazopanib Impurity 27 | Pazopanib Impurity 27. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 5-amino-N-(4-(bis(5-amino-2-methylphenyl)methyl)phenyl)-2-methylbenzenesulfonamide. CAS No. 1226500-00-0. Molecular Formula: C28H30N4O2S. Mole Weight: 486.63. Catalog: APB1226500000. | |
| Pazopanib Impurity 3 | An impurity of Pazopanib which is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms. Grades: > 95%. CAS No. 221681-95-1. Molecular formula: C10H13N2. Mole weight: 161.23. | |
| Pazopanib Impurity 3 | Pazopanib Impurity 3. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C18H23N5. Mole Weight: 309.42. Catalog: APB08871. | |
| Pazopanib Impurity 4 | Pazopanib Impurity 4. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C16H16N4O4. Mole Weight: 328.33. Catalog: APB08872. | |
| Pazopanib Impurity 5 | Pazopanib Impurity 5. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C16H22N4. Mole Weight: 270.38. Catalog: APB08869. | |
| Pazopanib Related Compound 1 | An impurity of Pazopanib whic is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM, respectively. Synonyms: 6-Chloropyrimidin-2(1H)-one; 80927-55-5; 6-chloro-1H-pyrimidin-2-one; chloropyrimidone; 4-Chloro-pyrimidin-2-ol; 2(1H)-Pyrimidinone, 4-chloro- (6CI,9CI); 4-CHLORO-2-HYDROXYPYRIMIDINE; 4-chloropyrimidone; chlorohydroxypyrimidine; SCHEMBL497452; 4-chloropyrimidin-2(1H)-one; AMY219; 4-CHLOROPYRIMIDIN-2-OL; 2(1H)-pyrimidinone,4-chloro-; DTXSID10531552; KVHNGYWHLLJFNQ-UHFFFAOYSA-N; MFCD13189457; AKOS006355688; AB68453; DS-4922; CS-0094249. Grades: > 95%. CAS No. 80927-55-5. Molecular formula: C4H3ClN2O. Mole weight: 130.53. | |
| Pazopanib Related Compound 2 | An impurity of Pazopanib whic is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM, respectively. Grades: > 95%. CAS No. 1226500-02-2. Molecular formula: C26H23ClN10. Mole weight: 510.99. | |
| Pazopanib Related Compound 3 | An impurity of Pazopanib which is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms. Grades: > 95%. CAS No. 1252927-44-8. Molecular formula: C27H25ClN10. Mole weight: 525.02. | |
| Pazopanib Related Compound 4 | An impurity of Pazopanib whic is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM, respectively. Synonyms: 3-Amino-4-methylbenzenesulfonamide. Grades: > 95%. CAS No. 6274-28-8. Molecular formula: C7H10N2O2S. Mole weight: 186.23. | |
| 1,3-dimethyl-1H-indazol-6-amine | 1,3-dimethyl-1H-indazol-6-amine is an impurity in the synthesis of Pazopanib (P210925) which is an oral angiogenesis inhibitor targeting VEGFR and PDGFR. It is used as a reagent in the preparation of glycinamide derivatives which are useful in production of drugs for preventing and treating diseases caused by S-adenosyl homocysteine hydrolase. Group: Biochemicals. Grades: Highly Purified. CAS No. 221681-92-1. Pack Sizes: 2.5mg, 5mg. Molecular Formula: C9H11N3, Molecular Weight: 161.199999999999. US Biological Life Sciences. | Worldwide |
| 1,3-dimethyl-1H-indazol-6-amine | 1,3-dimethyl-1H-indazol-6-amine is an impurity in the synthesis of Pazopanib, which is a potent and selective multi-targeted receptor tyrosine kinase inhibitor for the treatment of renal cell carcinoma and soft tissue sarcoma. Synonyms: 1H-Indazol-6-amine, 1,3-dimethyl-; 1,3-Dimethyl-6-amino-1H-indazole; Pazopanib Impurity 17; 1,3-Dimethyl-1H-indazol-6-ylamine; Pazopanib Impurity 3. Grades: 97.0%. CAS No. 221681-92-1. Molecular formula: C9H11N3. Mole weight: 161.20. | |
| 1,3-dimethyl-6-nitro-1H-indazole | 1,3-dimethyl-6-nitro-1H-indazole is an impurity in the synthesis of Pazopanib (P210925) hydrochloride, an oral angiogenesis inhibitor targeting VEGFR and PDGFR. Group: Biochemicals. Grades: Highly Purified. CAS No. 1354224-47-7. Pack Sizes: 2.5mg, 5mg. Molecular Formula: C9H9N3O2, Molecular Weight: 191.19. US Biological Life Sciences. | Worldwide |
| 2,3-Dimethyl-2H-indazol-6-ylamine | 2,3-Dimethyl-2H-indazol-6-ylamine is a reagent used in the synthesis of Pazopanib derivatives as antitumor agents. Group: Biochemicals. Grades: Highly Purified. CAS No. 444731-72-0. Pack Sizes: 250mg, 1g. Molecular Formula: C9H11N3, Molecular Weight: 161.199999999999. US Biological Life Sciences. | Worldwide |
| 2,3-Dimethyl-6-nitro-2H-indazole | 2,3-Dimethyl-6-nitro-2H-indazole (CAS# 444731-73-1) is an impurity in the synthesis of Pazopanib (P210925) hydrochloride, an oral angiogenesis inhibitor targeting VEGFR and PDGFR. Synonyms: 2,3-dimethyl-6-nitroindazole; 2,3-dimethyl-6-nitroindazole. Grades: 98 %. CAS No. 444731-73-1. Molecular formula: C9H9N3O2. Mole weight: 191.19. | |
| 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide | 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide. Group: Biochemicals. Alternative Names: Votrient; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide; Pazopanib. Grades: Highly Purified. CAS No. 444731-52-6. Pack Sizes: 25mg, 50mg, 100mg, 250mg, 500mg. Molecular Formula: C21H23N7O2S. US Biological Life Sciences. | Worldwide |
| 6-Amino-2,3-dimethyl-2H-indazole Hydrochloride | An impurity of Pazopanib, which is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms. Synonyms: 2H-Indazol-6-amine, 2,3-dimethyl-, hydrochloride (1:1); 2H-Indazol-6-amine, 2,3-dimethyl-, monohydrochloride; 2,3-Dimethyl-2H-indazol-6-amine hydrochloride; 2,3-Dimethyl-6-amino-2H-indazole hydrochloride. Grades: ≥95%. CAS No. 635702-60-2. Molecular formula: C9H12ClN3. Mole weight: 197.66. | |
| GSK-1071306 | GSK-1071306 is one of the metabolites of pazopanib which is a inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity as a approved drug. Synonyms: GSK-1071306; GSK1071306; GSK 1071306; Pazopanib metabolite M27;5-((4-((2,3-dimethyl-2H-indazol-6-yl)amino)-2-pyrimidinyl)amino)-2-methyl-Benzenesulfonamide. Grades: 98%. CAS No. 1252927-47-1. Molecular formula: C20H21N7O2S. Mole weight: 423.49. | |
| GSK-1268992 | GSK-1268992 is one of a metabolite of Pazopanib which is a selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis. Synonyms: GSK-1268992; GSK1268992; GSK 1268992; Pazopanib metabolite M24;5-((4-((3-(Hydroxymethyl)-2-methyl-indazol-6-yl)-methyl-amino)pyrimidin-2-yl)amino)-2-methyl-benzenesulfonamide. Grades: 98%. CAS No. 1414375-49-7. Molecular formula: C21H23N7O3S. Mole weight: 453.52. | |
| GSK-1268997 | GSK-1268997 is one of a metabolite of Pazopanib which is a selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis. Synonyms: GSK-1268997; GSK1268997; GSK 1268997; Pazopanib metabolite M26; 5-((4-((2,3-Dimethylindazol-6-yl)-methyl-amino)pyrimidin-2-yl)amino)-2-(hydroxymethyl)benzenesulfonamide. Grades: 98%. CAS No. 1414375-50-0. Molecular formula: C21H23N7O3S. Mole weight: 453.52. | |
| N-(2-Chloro-4-pyrimidinyl)-2,3-dimethyl-2H-indazol-6-amine | N-(2-Chloro-4-pyrimidinyl)-2,3-dimethyl-2H-indazol-6-amine. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: GW 790323X,Pazopanib related. CAS No. 444731-74-2. Pack Sizes: 1G. IUPAC Name: N-(2-chloropyrimidin-4-yl)-2,3-dimethylindazol-6-amine. Molecular Formula: C13H12ClN5. Mole Weight: 273.7209. Catalog: APS444731742. SMILES: Cc1c2ccc(Nc3ccnc(Cl)n3)cc2nn1C. Format: Neat. Shipping: Room Temperature. | |
Our database is helping our users find suppliers everyday.
